gmi research logo
GMI Research
See the Future Insights
GMI Research Facebook Page GMI Research Twitter Page GMI Research Linkedin Page
U.S Office +1 860 881 2270 : Europe Office +353 1 442 8820  

Global Neurostimulation Market by Product Type (Implantable {Deep Brain Stimulators, Sacral Nerve Stimulator, Spinal Cord Stimulators, Vagus Nerve Stimulators and Others} and Non-implantable {Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS)}), By Indication (Chronic pain, Movement disorders, Epilepsy and others), By End User (Hospitals, Ambulatory Surgical Centers and Specialty Clinics), and by Geography - Opportunities & Forecast, 2018-2025

Get Free 20% Customization in this Report


Report Code : HM27A-00-1118 Published Date: November-2018 Report Format: PPT

 

Select License Type:

Need Assitance ?


A GMI Research Sales Representative
is available to help you

U.S Office +1 860 881 2270

Europe Office +353 1 442 8820


The global neurostimulation market was valued at USD 5,716.5 million in 2017, and is projected to reach USD 14,476.4 million by the end of 2025, growing at a CAGR of 12.6% during 2018–2025.

Figure 1: Global Neurostimulation Market Revenue, 2018–2025 (USD Million)

Source: GMI Research


The key factors bolstering the market growth are increasing prevalence of neurological disorders, such as epilepsy, Parkinson’s disease, dystonia, depression, migraine, and chronic pain. In addition, strong clinical needs, expanding research activities and advances in neural stimulation technology in combination with a deeper understanding of the nervous system are also expected to aid the market growth.

Based on product type, implantable spinal cord stimulators segment is anticipated to lead the market during 2018–2025

Implantable spinal cord stimulators product type segment is expected to dominate the market during the forecast period due to an increase in clinical trials for the treatment of new indications. Moreover, the adoption of spinal cord stimulators is high as compared to conventional treatments as spinal cord stimulation procedure is minimally invasive, provides quicker recovery and is cost-effective.

The chronic pain by indication segment held the largest share in 2017 in the market, and is predicted to exhibit a significant growth rate during the forecast period owing to rising patients’ emphasis on timely and effective pain management and increase in prevalence of chronic pain disorder, globally. For instance, according to the American Academy of Pain Medicine, in 2011, more than 100.0 million people were affected by the chronic pain in the United States. Also, extensive research and development activities and the introduction of advanced neurostimulation products are predicted to aid the market growth in the coming years.
 

Players, such as Boston Scientific Corporation, Medtronic plc, Cyberonics, Inc., and Nevro Corp are focusing on R&D activities to expand their product portfolio.                                                                                                          


Figure 2: Global Neurostimulation Market Revenue, by Region, 2017

Source: GMI Research



Based on geography, North America held the largest share in the market in 2017 due to the presence of well-developed healthcare infrastructure, growing awareness among individuals about neurostimulation, and increasing adoption of neurostimulation procedures in the region. Asia-Pacific is the fastest growing region in global neurostimulation market and is projected to grow at CAGR of 14.2% during 2018-2025 due to the presence of a large patient pool, rising disposable income, etc.

Various notable players operating in the market include Boston Scientific Corporation, Medtronic plc, Cyberonics, Inc., Nevro Corp, NeuroPace, Inc., DePuy Synthes, NeuroSigma, Inc., Synapse Biomedical Inc., MED-EL., among others.


The global neurostimulation market has been segmented on the basis of product type, indication, end user, and key geographies. Based on the product type, global neurostimulation market has been segmented into implantable and non-implantable. Wherein, the implantable segment includes deep brain stimulators, sacral nerve stimulators, spinal cord stimulators, vagus nerve stimulators, and others and non-implantable segment includes transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). Based on indication type, global neurostimulation market has been segmented into chronic pain, movement disorders, epilepsy, and others. Based on end user, the market has been segmented into hospitals, ambulatory surgical centers, and specialty clinics.

The research report “global neurostimulation market” provides in-depth analysis of neurostimulation market, globally, based on product type, indication, end user and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers fueling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for neurostimulation market. The report also analyzes the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:
1-    At what pace is neurostimulation market growing, globally? What will be the growth trend in future?
2-    What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints over the coming years?
3-    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the neurostimulation market?
4-    What are the various application areas and how they are poised to grow?

Request TOC

First Name* :
Last Name* :
Report Title* :
Company Name* :
E-mail* :
Phone No.* :
Address :
City* :
State* :
Country* :
Zip Code* :
Verification Code* : captcha